表紙
市場調查報告書
商品編碼
1008243

癌症替代療法的全球市場(2021年∼2028年)

Global Alternative Cancer Treatment Market - 2021-2028

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

癌症替代療法市場成長的主要因素有各種癌症的流行,包括結直腸癌、前列腺癌、淋巴瘤、白血病、肺癌、乳腺癌和黑色素瘤。此外,預計針灸和脊椎按摩療法等天然替代療法和補充療法的意識不斷增強,預計將在預計期間推動市場發展。

然而,IPT-胰島素增強療法、Ukline TM、Gelson療法、Iscadol(Yadorigi提取物)、生物療法排毒引流、生物磁療法等主要癌症替代療法治療癌症的範圍狹窄,此外其低效和影響阻礙市場增長。

本報告提供全球癌症替代療法市場的相關調查,提供市場機會和影響,成長及阻礙因素,療法類型·疾病適應症·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 全球癌症替代療法市場調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 全球癌症替代療法市場-市場定義和概要

第3章 全球癌症替代療法市場-摘要整理

  • 各療法類型的市場明細
  • 各疾病適應症市場明細
  • 各終端用戶市場明細
  • 各地區的市場明細

第4章 全球癌症替代療法市場-市場動態

  • 影響市場的要素
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球癌症替代療法市場-產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球癌症替代療法市場-COVID-19分析

  • 市場上的Covid-19分析
    • COVID-19前的市場方案
    • 當前的 COVID-19 市場情景
    • COVID-19後的市場方案或未來情景
  • Covid-19的價格趨勢
  • 需求與供給的頻譜
  • 疫情期間與市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球癌症替代療法市場-各療法類型

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析
    • 市場魅力指數
  • 荷爾蒙療法
    • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(2020-2028)
  • 針灸治療和營養補充品
  • 其他

第8章 全球癌症替代療法市場-各疾病適應症

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析
    • 市場魅力指數
  • 腸胃
    • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(2020-2028)
  • 肺癌症
  • 乳癌
  • 結腸直腸癌症
  • 白血病
  • 其他

第9章 全球癌症替代療法市場-各終端用戶

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析
    • 市場魅力指數
  • 醫院
    • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(2020-2028)
  • 診所
  • 居家照護

第10章 全球癌症替代療法市場-各地區

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(2020-2028):各地區
    • 各地區的市場魅力指數
  • 北美
    • 簡介
    • 主要每個地區的動態
    • 各療法類型:市場規模分析,及與前一年同期比較成長分析
    • 各疾病適應症:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 歐洲
    • 簡介
    • 主要每個地區的動態
    • 各療法類型:市場規模分析,及與前一年同期比較成長分析
    • 各疾病適應症:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 南美
    • 簡介
    • 主要每個地區的動態
    • 各療法類型:市場規模分析,及與前一年同期比較成長分析
    • 各疾病適應症:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 亞太地區
    • 簡介
    • 主要每個地區的動態
    • 各療法類型:市場規模分析,及與前一年同期比較成長分析
    • 各疾病適應症:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析
    • 各國:市場規模分析,及與前一年同期比較成長分析
  • 中東和非洲
    • 簡介
    • 主要每個地區的動態
    • 各療法類型:市場規模分析,及與前一年同期比較成長分析
    • 各疾病適應症:市場規模分析,及與前一年同期比較成長分析
    • 各終端用戶:市場規模分析,及與前一年同期比較成長分析

第11章 全球癌症替代療法市場-競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準

第12章 全球癌症替代療法市場-企業簡介概要

  • Amgen Inc
    • 企業概要
    • 產品系列·概要
    • 要點
    • 財務概要
  • Innovative Medicine, LLC
  • Northwest Natural Health Clinic
  • Immunotherapy Institute
  • Georgia Cancer Specialists
  • Holistic Bio Spa
  • Esperity,
  • Bristol-Myers Squibb Company
  • Merck & Co. Inc.
  • Celgene Corporation

第13章 全球癌症替代療法市場-DataM

  • 附錄
  • 關於本公司·服務
  • 諮詢方式
目錄
Product Code: DMPH3407

Market Overview

The global alternative cancer treatment market size was valued US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Alternative cancer treatments are now actively involved in restricting the growth of cancer. These treatments are also recognized as precision medicines. Recently alternative cancer treatment has gained rising focus in the industry as these therapies form that utilizes complementary and alternative methods or methods to prevent and treat cancer at an earlier stage.

Market Dynamics

The alternative cancer treatment market growth is driven by the growing prevalence of various types of cancers such as colorectal cancer, prostate cancer, lymphoma, leukaemia, lung cancer, breast cancer, melanoma an other. Also increasing awareness regarding natural alternative and complementary therapies such as acupuncture and chiropractic therapy is expected to drive the market over the forecast period.

The rising burden of cancer across the globe is driving the market growth

As per the Globocan 2020 fact sheet, an expected 19,292,789 new cancer cases were treated worldwide, with approximately 9,958,133 deaths due to cancers globally. In addition, as per the estimates from the International Agency for Research on Cancer, by 2040, the global burden of cancers is anticipated to grow to 27.5 million new cancer cases and 16.3 million deaths worldwide. The growing incidence of cancer cases is anticipated to drive the need for an alternative cancer treatment market.

Prostate cancer is the second most prevalent type of cancer in the male population. About 80% of men who reach 80 years of age are diagnosed with it. As per the data published by Globocan 2020, the prevalence of prostate cancer was found to be 1,414,259 or 7.3% of the total cancer cases worldwide.

As prostate cancer is more prevalent in the elderly population, the rising aging population is also expected to propel market growth. For instance, as per World Population Ageing Report 2019, there were 703 million people aged 65 years or over in the world in 2019, and this number of older persons is projected to double and reach 1.5 billion in 2050.

Thus, given the aforementioned factors, the alternative cancer treatment market is expected to witness tremendous growth over the forecast period.

Low effectiveness and impact of the top alternative cancer therapies will hamper the market growth

However, the market is hindered by the low effectiveness and impact of the top alternative cancer therapies like IPT- insulin potentiation therapy, UkrainTM, Gerson Therapy, iscador aka mistletoe extracts, biotherapeutic detoxification and drainage, and biomagnetic therapy, among others, along with less coverage to cure cancer.

COVID-19 Impact Analysis

The COVID-19 pandemic has impacted the healthcare systems globally and also has a notable impact on the market. As per the article written in Cancer Connect 2020, doctors from Dana Farber Cancer Institute determined that while the COVID-19 pandemic, there was a 46% reduction in the diagnoses of the six most prevalent cancer types pancreatic, gastric, breast, colorectal, lung and esophageal cancers. Additionally, the Centers for Disease Control and several medical professional organizations suggested that cancer screening and other health prevention services be postponed except the risks outweighed the benefits and ensure the hospital infrastructure for the treatment of COVID-19 patients. Thus, the COVID-19 pandemic has affected the alternative cancer treatment market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Hormone therapies segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Hormone therapy is recognized as a systemic treatment because the hormones they target flow in the body. The drugs used in hormone therapy travel everywhere the body to target and find the hormones. It makes several treatments that affect only a specific part of the body, like most surgery and radiation therapy types. Treatments like these are called local treatments because they influence one part of the body.

Hormone therapy is available in pills, injections and surgery that eliminates hormone-producing organs, particularly the ovaries in women and the testicles in men. It's typically prescribed, along with other cancer treatments.

Because hormone treatment blocks the body's ability to produce hormones or interferes with how hormones behave, it can cause undesired side effects. The side effects will depend on the type of hormone therapy you receive and how the body reacts. People react differently to the same treatment, so not everyone gets the equivalent side effects. Some side effects also change in a man or a woman.

The lung cancer segment are expected to dominate the alternative cancer treatment market during the forecast period

Lung Cancer is the deadly lung tumor described by the undisciplined growth of cells in the lung tissues. Cigarette smoking is the leading risk factor for the growth of lung cancer. Prolonged exposure to tobacco smoke can also create lung cancer. In addition, the raised funding in the field of R&D of new drugs, growing pollution due to rapid industrialization, an increased number of smokers are one reason for the increasing prevalence of lung cancer.

There are many types of primary lung cancer, and they are separated into Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). Among the two types of lung cancer, NSCLC is more prevalent. As per the Cancer Research 2017 data, about 87% of the lung cancers in the UK are NSCLC. Lung cancer is also one of the most prevalent types of cancer. As per the American Society of Clinical Oncology 2019 report, lung cancer advances up about 13% of all new cancer diagnoses.

The global pervasiveness of cancer is increasing, as per a Cancer Research UK report. The report suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the number of significant cancers and population growth are consistent, it is prophesied there will be 27.5 million new cancer cases worldwide each year by 2040. This is an expansion of 61.7% from 2018 (17 million). This factor will increase the demand for alternative cancer treatment, which will help the market growth.

Geographical Analysis

North America region holds the largest market share in the global alternative cancer treatment market

North America region is dominating the global alternative cancer treatment market accounted for the largest market share in 2020. According to the American Society of Clinical Oncology 2019 report, an expected 228,150 adults in the United States were expected to be diagnosed with lung cancer. Lung cancer causes up about 13% of all new cancer treatments. Lung cancer is the second common cancer and the foremost cause of cancer death for adults in the US. The report predicted that 142,670 deaths from this disease would occur in the year 2019.

However, North American countries such as the United States and Canada have an advanced and well-structured health care system. These systems also support research and development. These policies support global players to penetrate the US and Canada markets. As a result, these nations enjoy the presence of many market players. As global players in the region meet the high requirement, the market is further expected to increase in the forecast period.

Competitive Landscape

The alternative cancer treatment market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Innovative Medicine, LLC, Northwest Natural Health Clinic, Immunotherapy Institute, Georgia Cancer Specialists, Holistic Bio Spa, Esperity, and Merck & Co. Inc., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the alternative cancer treatment market globally.

Innovative Medicine, LLC

  • Overview: Innovative Medical Solutions LLC is headquartered in the United States. The first medical center for Innovative Medicine has been established in New York City where patients seek treatment from all over the world.
  • Product Portfolio: The Company's portfolio comprised of wholesale distribution of surgical and other medical instruments, apparatus, and equipment.

Why Purchase the Report?

  • Visualize the composition of the alternative cancer treatment market segmentation by therapy type, disease indication and end user highlighting the key commercial assets and players.
  • Identify commercial opportunities in alternative cancer treatment market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of alternative cancer treatment market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global alternative cancer treatment market report would provide an access to an approximately 45+ market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Alternative Cancer Treatment Market - By Therapy Type

  • Hormone Therapies
  • Acupuncture and Dietary Supplements
  • Ayurveda
  • Traditional Japanese Medicine
  • Traditional Chinese Medicine
  • Others

Global Alternative Cancer Treatment Market- By Disease Indication

  • Gastrointestinal
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Others

Global Alternative Cancer Treatment Market -By End User

  • Hospitals
  • Clinics
  • Home Care

Global Alternative Cancer Treatment Market - By Region

  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Global Alternative Cancer Treatment Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Alternative Cancer Treatment Market - Market Definition and Overview

3. Global Alternative Cancer Treatment Market - Executive Summary

  • 3.1. Market Snippet by Therapy Type
  • 3.2. Market Snippet by Disease Indication
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Global Alternative Cancer Treatment Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising burden of cancer across the globe is driving the market growth
      • 4.1.1.2. The rising healthcare expenditure and growing insurance coverage is driving the market growth
    • 4.1.2. Restraints:
      • 4.1.2.1. Low effectiveness and impact of the top alternative cancer therapies will hamper the market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Alternative Cancer Treatment Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Alternative Cancer Treatment Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Alternative Cancer Treatment Market - By Therapy Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type Segment
    • 7.1.2. Market Attractiveness Index, By Therapy Type Segment
  • 7.2. Hormone Therapies*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Acupuncture and Dietary Supplements
  • 7.4. Ayurveda
  • 7.5. Traditional Japanese Medicine
  • 7.6. Traditional Chinese Medicine
  • 7.7. Others

8. Global Alternative Cancer Treatment Market - By Disease Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 8.1.2. Market Attractiveness Index, By Disease Indication
  • 8.2. Gastrointestinal Cancer*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Lung Cancer
  • 8.4. Breast Cancer
  • 8.5. Colorectal Cancer
  • 8.6. Leukemia
  • 8.7. Others

9. Global Alternative Cancer Treatment Market - By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 9.1.2. Market Attractiveness Index, By End User Segment
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Clinics
  • 9.4. Home Care

10. Global Alternative Cancer Treatment Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Alternative Cancer Treatment Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of key companies to watch
  • 11.5. List of the company with disruptive technology
  • 11.6. List of start-up companies

12. Global Alternative Cancer Treatment Market- Company Profiles

  • 12.1. Pure encapsulations, LLC *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Innovative Medicine, LLC
  • 12.3. Northwest Natural Health Clinic
  • 12.4. Immunotherapy Institute
  • 12.5. Georgia Cancer Specialists
  • 12.6. Holistic Bio Spa
  • 12.7. Esperity
  • 12.8. Nordic Nutraceuticals
  • 12.9. Merck & Co. Inc.
  • 12.10. Celgene Corporation (*LIST NOT EXHAUSTIVE)

13. Global Alternative Cancer Treatment Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us